Latest Breaking News On - Topline results - Page 1 : vimarsana.com

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

John quiselGayle rossGuowen liuNaseema gangatAmy dickeyChristina tartagliaDisc medicine incEuropean hematology associationVerge scientific communicationsExchange commissionMadrid spainChief executive officerDisc medicineTopline resultsPlacebo controlled trialOpen label trial

Enlivex Therapeutics : Report of Periodic or Interim Report

Enlivex Therapeutics : Report of Periodic or Interim Report
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNess zionaState of israelOren hershkovitzFiler is shell companyEnlivex therapeutics ltdTherapeutics rd ltdCompany contact person securitiesSubsidiaries of enlivex therapeutics ltdUs centers for diseaseIsraeli ministry of healthSecurities exchangeExchange commissionEdgar agentsInternational financial reporting standardsGrowth company

Trials reveal that internet-based conversations help sustain brain function in older adults

Trials reveal that internet-based conversations help sustain brain function in older adults
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesResearch analyticsInterdisciplinary brain center at massachusettsHarvard medical schoolMassachusetts general hospitalUnited states surgeon generalSurgeon general advisoryInterdisciplinary brain centerHarvard medicalHirokoh dodgeAmong socially isolated adultsYears old with normal cognitionMild cognitive impairmentTopline results

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

AXS-12 statistically significantly reduced cataplexy attacks compared to placebo AXS-12 achieved statistically significant remission of cataplexy compared to placebo AXS-12 statistically.

New yorkUnited statesMark jacobsonDarren oplandMichael thorpyAxsome therapeutics incWake disorders centerCorporate communicationsDrug administrationWorld trade centerMontefiore medical centerCognitive functionSleep wake disorders centerAlbert einstein collegeClinician global impressionNarcolepsy symptom assessment questionnaire

Cytokinetics Reports Fourth Quarter 2023 Financial Results

Cytokinetics Reports Fourth Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJi xingRoberti blumCytokinetics diane weiserseniorOffice of new drugsOngoing researchResearch evaluation of sustained treatmentInternational symposiumExchange commissionUs food drug administrationCytokinetics incorporated nasdaqClinical developmentCommittee for medicinal products human useSkeletal muscle programCorporate communicationsEuropean medicines agency